2023-10-26T09:49:19-05:00 2022-12-31 812950760 SAX LLP 1040 AVENUE OF THE AMERICAS-16TH FL NEW YORK NY 10018 990 2022-01-01 842711222 EYELLIANCE INC EYEL 9174343099 110 EAST 25TH STREET NEW YORK NY 10010 ELIZABETH SMITH CO-FOUNDER/CEO 9174343099 2023-10-26 1 ELIZABETH SMITH 999009999 0 MIKE SCHALL P02024184 2126618640 2023-10-20 3 AAL1 IAL1 2022 2023-04-26 12:10:37Z ELIZABETH SMITH 110 EAST 25TH STREET NEW YORK NY 10010 4096856 0 X HTTPS://WWW.EYELLIANCE.ORG/ X 2020 DE ACCELERATE EQUITABLE ACCESS TO EYEGLASSES FOR ONE BILLION PEOPLE. 6 5 6 6 0 0 1391346 4096856 0 0 0 0 6800 0 1398146 4096856 56333 426971 0 0 595467 747399 0 0 214074 523879 758511 1175679 1932881 222467 2163975 1329557 3541266 16046 63780 1313511 3477486 ACCELERATE EQUITABLE ACCESS TO EYEGLASSES FOR ONE BILLION PEOPLE. EYELLIANCE ADVANCES FOUR MUTUALLY REINFORCING GLOBAL AND NATIONAL STRATEGIES, GOV DELIVERY, SUSTAINABLE FINANCING, INSTITUTIONAL ADVOCACY, AND CATALYTIC PARTNERSHIPS. 0 0 498877 320228 INFLUENCE GLOBAL AGENDAS 1003625 106743 SCALING PATHWAYS 1502502 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 1 1 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 9 0 1 6 1 0 0 0 0 0 0 0 0 0 0 0 0 X 6 5 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 0 0 NY DE X ELIZABETH SMITH 9174343099 110 EAST 25TH STREET NEW YORK NY 10010 ELIZABETH SMITH CO-FOUNDER/CEO 40.00 X X 162673 0 38604 JAYANTH BHUVARAGHAN BOARD CHAIRMAN 0.50 X X 0 0 0 DR JORDON KASSALOW CO-FOUNDER 7.00 X 0 0 0 CHRIS JURGENS DIRECTOR 0.25 X 0 0 0 ALEX PALACIOS DIRECTOR 0.25 X 0 0 0 HARVEY KOH DIRECTOR 0.25 X 0 0 0 ABIGAIL MCDANIEL GLOBAL TECH LEAD 40.00 X 111826 0 48573 MAGGIE SAVAGE VP OF OPERATIONS 40.00 X 123560 0 38922 398059 0 126099 3 0 1 0 0 4096856 4096856 4096856 0 0 0 X 200000 200000 226971 226971 214279 112864 12752 88663 444097 386032 9201 48864 13557 12126 203 1228 28375 28375 47091 36260 1413 9418 199 199 75821 75821 300623 217325 35576 47722 11428 7295 3359 774 7815 6018 234 1563 71308 54907 2139 14262 68123 52645 15478 122169 122169 7899 6082 237 1580 PROFESSIONAL DEVELOPMEN 46269 46269 PROGRAM SUPPLIES 24045 24045 DUES & SUBSCRIPTIONS 13234 8179 5055 OTHER EXPENSES 9578 1209 8369 1932881 1502502 216305 214074 1307190 1532449 6935 1993250 15432 15567 1329557 3541266 16046 63780 16046 63780 X 1313511 1487486 1990000 1313511 3477486 1329557 3541266 2163975 0 X 0 1 X 1 0 X 1850036 1391346 4096856 7338238 1850036 1391346 4096856 7338238 3476478 3861760 7875 6800 14675 7352913 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 X 4121465 24609 24609 4096856 0 4096856 1957490 24609 24609 1932881 0 1932881 PART X, LINE 2: EYELLIANCE DOES NOT BELIEVE ITS FINANCIAL STATEMENTS INCLUDE ANY UNCERTAIN TAX POSITIONS. TAX FILINGS FOR PERIODS ENDING DECEMBER 31, 2020, EYELLIANCE'S INITIAL FILING, AND LATER ARE SUBJECT TO EXAMINATION BY APPLICABLE TAXING AUTHORITIES. 0 EUROPE (INCLUDING ICELAND & GREENLAND) GRANT MAKING 89332 SOUTH ASIA GRANT MAKING 87181 SUB-SAHARAN AFRICA GRANT MAKING 49235 0 0 0 0 0 0 225748 0 225748 EUROPE (INCLUDING ICELAND & GREENLAND) DEVELOP AND INVEST IN SCALABLE AND SUSTAINABLE SOLUTIONS TO IMPROVE VISION CARE 89332 WIRE 0 SOUTH ASIA NATIONAL SCHOOL EYE HEALTH IN LIBERIA 87181 WIRE 0 SUB-SAHARAN AFRICA INCREASE ACCESS TO LOW COST OPTICAL FOR LOW AND MIDDLE INCOME CONSUMERS 49235 WIRE 0 0 0 0 0 0 0 PART III ACCOUNTING METHOD: 1 CLINTON HEALTH ACCESS INITIAT 383 DORCHESTER AVENUE STE 400 BOSTON MA 02127 271414646 501(C)(3) 200000 0 SCHOOL EYE HEALTH INITIATIVE 1 PART I, LINE 2: GRANTEE SHALL SUBMIT TO THE ORGANIZATION A FINAL WRITTEN REPORT THAT CONTAINS:1)A DESCRIPTION OF THE PROGRESS THAT GRANTEE HAS MADE TOWARD ACHIEVING THE PURPOSES FOR WHICH THE GRNAT WAS MADE; AND 2)A FINANCIAL ACCOUNTING OF THE EXPENDITURE OF GRANT FUNDS THAT WILL BE SUBJECT TO REVIEW BY THE ORGANIZATION PRIOR TO FINAL APPROVAL. X X 0 0 0 0 0 0 0 0 0 ELIZABETH SMITH CO-FOUNDER/CEO 162673 0 0 0 0 0 6744 0 31860 0 201277 0 0 0 MAGGIE SAVAGE VP OF OPERATIONS 123560 0 0 0 0 0 5450 0 33472 0 162482 0 0 0 ABIGAIL MCDANIEL GLOBAL TECH LEAD 111826 0 0 0 0 0 5421 0 43152 0 160399 0 0 0 FORM 990, PART VI, SECTION B, LINE 11B LINE 11B EXPLANATION - THE 990 IS DISTRIBUTED TO BOARD MEMBERS BY EMAIL AND APPROVAL THROUGH EMAIL IS REQUESTED. FORM 990, PART VI, SECTION B, LINE 12C YES, AS INDICATED IN OUR CONFLICT OF INTEREST POLICY: THE RESPONSIBILITY FOR IDENTIFYING POTENTIAL SELF-DEALING OF CONFLICT OF INTEREST RESTS WITH THE MEMBER.EACH DIRECTOR AND OFFICER MUST EVALUATE WHETHER POTENTIAL SELF-DEALING OR CONFLICT OF INTEREST EXIST AND IF SO, MUST DISCLOSE ALL RELEVANT FACTS AND CIRCUMSTANCES TO THE DIRECTORS. THE CONFLICT OF INTEREST POLICY IS SENT TO BOARD MEMBERS IN ADVANCE OF THE FIRST MEETING OF THE YEAR AND BOARD MEMBERS ARE REMINDED OF THEIR DUTY TO DISCLOSE. FORM 990, PART VI, SECTION B, LINE 15A CEO SALARY DECISIONS ARE MADE BY THE BOARD MEMBERS SUPPORTED BY RELEVANT SALARY SURVEYS, CEO SETS SALARIES FOR ALL OTHER STAFF. FORM 990, PART VI, SECTION C, LINE 19 FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST FORM 990, PART IX, LINE 11G HONORARIA/STIPENDS: PROGRAM SERVICE EXPENSES 0. MANAGEMENT AND GENERAL EXPENSES 7,500. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 7,500. CONSULTANT: PROGRAM SERVICE EXPENSES 104,972. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 10,883. TOTAL EXPENSES 115,855. OTHER PROFESSIONAL FEES: PROGRAM SERVICE EXPENSES 112,353. MANAGEMENT AND GENERAL EXPENSES 28,076. FUNDRAISING EXPENSES 36,839. TOTAL EXPENSES 177,268.